PYC Therapeutics Limited

ASX:PYC Stock Report

Market Cap: AU$415.9m

PYC Therapeutics Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Rohan Hockings

Chief executive officer

AU$437.5k

Total compensation

CEO salary percentage90.3%
CEO tenure3.7yrs
CEO ownershipn/a
Management average tenure3.7yrs
Board average tenure4.8yrs

Recent management updates

Recent updates

Companies Like PYC Therapeutics (ASX:PYC) Are In A Position To Invest In Growth

Apr 10
Companies Like PYC Therapeutics (ASX:PYC) Are In A Position To Invest In Growth

Is PYC Therapeutics (ASX:PYC) In A Good Position To Deliver On Growth Plans?

Nov 10
Is PYC Therapeutics (ASX:PYC) In A Good Position To Deliver On Growth Plans?

We Think PYC Therapeutics (ASX:PYC) Needs To Drive Business Growth Carefully

Jul 03
We Think PYC Therapeutics (ASX:PYC) Needs To Drive Business Growth Carefully

Here's Why We're Watching PYC Therapeutics' (ASX:PYC) Cash Burn Situation

Jan 25
Here's Why We're Watching PYC Therapeutics' (ASX:PYC) Cash Burn Situation

Companies Like PYC Therapeutics (ASX:PYC) Are In A Position To Invest In Growth

Jul 31
Companies Like PYC Therapeutics (ASX:PYC) Are In A Position To Invest In Growth

We're Not Very Worried About PYC Therapeutics' (ASX:PYC) Cash Burn Rate

Mar 28
We're Not Very Worried About PYC Therapeutics' (ASX:PYC) Cash Burn Rate

Non-Executive Chair of the Board Alan Tribe Just Bought A Handful Of Shares In PYC Therapeutics Limited (ASX:PYC)

Feb 20
Non-Executive Chair of the Board Alan Tribe Just Bought A Handful Of Shares In PYC Therapeutics Limited (ASX:PYC)

Have Insiders Been Selling PYC Therapeutics Limited (ASX:PYC) Shares?

Jan 26
Have Insiders Been Selling PYC Therapeutics Limited (ASX:PYC) Shares?

What You Need To Know About PYC Therapeutics Limited's (ASX:PYC) Investor Composition

Dec 22
What You Need To Know About PYC Therapeutics Limited's (ASX:PYC) Investor Composition

We Think PYC Therapeutics (ASX:PYC) Can Easily Afford To Drive Business Growth

Nov 17
We Think PYC Therapeutics (ASX:PYC) Can Easily Afford To Drive Business Growth

CEO Compensation Analysis

How has Rohan Hockings's remuneration changed compared to PYC Therapeutics's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023n/an/a

-AU$22m

Sep 30 2023n/an/a

-AU$22m

Jun 30 2023AU$438kAU$395k

-AU$23m

Mar 31 2023n/an/a

-AU$23m

Dec 31 2022n/an/a

-AU$24m

Sep 30 2022n/an/a

-AU$19m

Jun 30 2022AU$418kAU$395k

-AU$14m

Mar 31 2022n/an/a

-AU$15m

Dec 31 2021n/an/a

-AU$17m

Sep 30 2021n/an/a

-AU$17m

Jun 30 2021n/an/a

-AU$18m

Mar 31 2021n/an/a

-AU$15m

Dec 31 2020n/an/a

-AU$12m

Sep 30 2020n/an/a

-AU$9m

Jun 30 2020AU$471kAU$395k

-AU$7m

Mar 31 2020n/an/a

-AU$6m

Dec 31 2019n/an/a

-AU$5m

Sep 30 2019n/an/a

-AU$5m

Jun 30 2019AU$482kAU$395k

-AU$4m

Mar 31 2019n/an/a

-AU$4m

Dec 31 2018n/an/a

-AU$5m

Sep 30 2018n/an/a

-AU$6m

Jun 30 2018AU$377kAU$84k

-AU$7m

Compensation vs Market: Rohan's total compensation ($USD284.66K) is below average for companies of similar size in the Australian market ($USD638.13K).

Compensation vs Earnings: Rohan's compensation has increased whilst the company is unprofitable.

CEO

Rohan Hockings (40 yo)

3.7yrs

Tenure

AU$437,500

Compensation

Dr. Rohan Hockings, MBBS (Hons.), J.D., G.D.L.P, has been Chief Executive Officer at PYC Therapeutics Limited since August 2020. He served as Chief Strategy Officer at PYC Therapeutics Limited until August...

Leadership Team

NamePositionTenureCompensationOwnership
Rohan Hockings
CEO & Executive Director3.7yrsAU$437.50kno data
Andrew Taylor
CFO & Company Secretary2yrsno datano data
Kevin Hart
Company Secretary6.8yrsAU$165.90kno data

3.7yrs

Average Tenure

Experienced Management: PYC's management team is considered experienced (3.7 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Rohan Hockings
CEO & Executive Director5.4yrsAU$437.50kno data
Michael Rosenblatt
Independent Non-Executive Director3.1yrsAU$142.87kno data
Stephen Doberstein
Member of Scientific Advisory Board6.5yrsno datano data
David Birch
Member of Ophthalmology Clinical Advisory Board2.7yrsno datano data
Judy Lieberman
Member of Scientific Advisory Board6.5yrsno datano data
Shohei Koide
Member of Scientific Advisory Board5.3yrsno datano data
Jason Haddock
Independent Director3.1yrsAU$142.87kno data
Alan Tribe
Non-Executive Chair of the Board6yrsAU$70.00k34.38%
A$ 143.0m
Rakesh Veedu
Member of Scientific Advisory Board5.1yrsno datano data
Fred Chen
Member of Scientific Advisory Board & Member of Ophthalmology Clinical Advisory Board4.6yrsno datano data
Mark Pennesi
Member of Ophthalmology Clinical Advisory Board2.7yrsno datano data
Jacque Duncan
Member of Ophthalmology Clinical Advisory Board2.7yrsno datano data

4.8yrs

Average Tenure

64yo

Average Age

Experienced Board: PYC's board of directors are considered experienced (4.8 years average tenure).

Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy PolicyLogos provided by Clearbit
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.